Driving immunization through the Medicare Annual Wellness Visit: A growing opportunity

Angela K. Shen, Rob Warnock, Jeffrey A. Kelman

Research output: Contribution to journalArticle

Abstract

Introduction: The Annual Wellness Visit (AWV) is a Medicare benefit designed to help prevent disease and disability based on individualized health and risk factors. Methods: This study analyzes Medicare Part B fee-for-service claims from 2011 to 2016 to assess AWV and seasonal influenza and pneumococcal conjugate vaccinations utilization over time. Results: Utilization of the AWV has increased from 8% of Medicare beneficiaries in 2011 to 19% in 2015. In each year, influenza and PCV13 vaccination rates are higher among those who utilize the benefit. More than one-third (33%) of patients who had an AWV in 2015 received a PCV13 vaccination in that same year, compared to 14% of those who did not. Similarly, the seasonal influenza vaccination rate was 64% among those with an AWV and 44% among those without. Conclusion: The AWV demonstrates promise for improving immunization rates among Medicare beneficiaries particularly at the point of care.

Original languageEnglish (US)
JournalVaccine
DOIs
StateAccepted/In press - 2017
Externally publishedYes

Fingerprint

Medicare
Immunization
immunization
Vaccination
vaccination
influenza
Human Influenza
Medicare Part B
Point-of-Care Systems
Fee-for-Service Plans
risk factors
Health
methodology

Keywords

  • Annual wellness visit
  • Centers for medicare & medicaid
  • Vaccination coverage

ASJC Scopus subject areas

  • Molecular Medicine
  • Immunology and Microbiology(all)
  • veterinary(all)
  • Public Health, Environmental and Occupational Health
  • Infectious Diseases

Cite this

Driving immunization through the Medicare Annual Wellness Visit : A growing opportunity. / Shen, Angela K.; Warnock, Rob; Kelman, Jeffrey A.

In: Vaccine, 2017.

Research output: Contribution to journalArticle

Shen, Angela K. ; Warnock, Rob ; Kelman, Jeffrey A. / Driving immunization through the Medicare Annual Wellness Visit : A growing opportunity. In: Vaccine. 2017.
@article{1b4ffc83143c428ab4d39d6455840224,
title = "Driving immunization through the Medicare Annual Wellness Visit: A growing opportunity",
abstract = "Introduction: The Annual Wellness Visit (AWV) is a Medicare benefit designed to help prevent disease and disability based on individualized health and risk factors. Methods: This study analyzes Medicare Part B fee-for-service claims from 2011 to 2016 to assess AWV and seasonal influenza and pneumococcal conjugate vaccinations utilization over time. Results: Utilization of the AWV has increased from 8{\%} of Medicare beneficiaries in 2011 to 19{\%} in 2015. In each year, influenza and PCV13 vaccination rates are higher among those who utilize the benefit. More than one-third (33{\%}) of patients who had an AWV in 2015 received a PCV13 vaccination in that same year, compared to 14{\%} of those who did not. Similarly, the seasonal influenza vaccination rate was 64{\%} among those with an AWV and 44{\%} among those without. Conclusion: The AWV demonstrates promise for improving immunization rates among Medicare beneficiaries particularly at the point of care.",
keywords = "Annual wellness visit, Centers for medicare & medicaid, Vaccination coverage",
author = "Shen, {Angela K.} and Rob Warnock and Kelman, {Jeffrey A.}",
year = "2017",
doi = "10.1016/j.vaccine.2017.10.055",
language = "English (US)",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Driving immunization through the Medicare Annual Wellness Visit

T2 - A growing opportunity

AU - Shen, Angela K.

AU - Warnock, Rob

AU - Kelman, Jeffrey A.

PY - 2017

Y1 - 2017

N2 - Introduction: The Annual Wellness Visit (AWV) is a Medicare benefit designed to help prevent disease and disability based on individualized health and risk factors. Methods: This study analyzes Medicare Part B fee-for-service claims from 2011 to 2016 to assess AWV and seasonal influenza and pneumococcal conjugate vaccinations utilization over time. Results: Utilization of the AWV has increased from 8% of Medicare beneficiaries in 2011 to 19% in 2015. In each year, influenza and PCV13 vaccination rates are higher among those who utilize the benefit. More than one-third (33%) of patients who had an AWV in 2015 received a PCV13 vaccination in that same year, compared to 14% of those who did not. Similarly, the seasonal influenza vaccination rate was 64% among those with an AWV and 44% among those without. Conclusion: The AWV demonstrates promise for improving immunization rates among Medicare beneficiaries particularly at the point of care.

AB - Introduction: The Annual Wellness Visit (AWV) is a Medicare benefit designed to help prevent disease and disability based on individualized health and risk factors. Methods: This study analyzes Medicare Part B fee-for-service claims from 2011 to 2016 to assess AWV and seasonal influenza and pneumococcal conjugate vaccinations utilization over time. Results: Utilization of the AWV has increased from 8% of Medicare beneficiaries in 2011 to 19% in 2015. In each year, influenza and PCV13 vaccination rates are higher among those who utilize the benefit. More than one-third (33%) of patients who had an AWV in 2015 received a PCV13 vaccination in that same year, compared to 14% of those who did not. Similarly, the seasonal influenza vaccination rate was 64% among those with an AWV and 44% among those without. Conclusion: The AWV demonstrates promise for improving immunization rates among Medicare beneficiaries particularly at the point of care.

KW - Annual wellness visit

KW - Centers for medicare & medicaid

KW - Vaccination coverage

UR - http://www.scopus.com/inward/record.url?scp=85032331183&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032331183&partnerID=8YFLogxK

U2 - 10.1016/j.vaccine.2017.10.055

DO - 10.1016/j.vaccine.2017.10.055

M3 - Article

C2 - 29089193

AN - SCOPUS:85032331183

JO - Vaccine

JF - Vaccine

SN - 0264-410X

ER -